Background Thirty countries with the highest tuberculosis (TB) burden bear 87% of the
world's TB cases. Delayed diagnosis and treatment are detrimental to TB prognosis and …

One of the strategies of the World Health Organization End Tuberculosis (TB) was to reduce
the catastrophic costs incurred by TB-affected families to 0% by 2020. Catastrophic cost is …

Objectives Extrapulmonary tuberculosis (EPTB) is not a notifiable infectious disease in
China but is a heavy burden on public health. However, the epidemic situation of EPTB …

Background: A direct benefit transfer (DBT) program was launched to address the dual
epidemic of under-nutrition and tuberculosis (TB) in India. We conducted this study to …

Objective To synthesise the evidence for estimating the direct and indirect patient costs of
drug‐sensitive and drug‐resistant tuberculosis care in India. Method PubMed, Embase, Web …

Background Tuberculosis (TB) is a major global health threat and the leading infectious
disease cause of death worldwide. Access to and retention in TB care remains a challenge …

Objectives This study aimed to assess the coverage and explore enablers and challenges in
implementation of direct benefit transfer (DBT) cash incentive scheme for patients with …

Importance The high household costs associated with tuberculosis (TB) diagnosis and
treatment can create barriers to access and adherence, highlighting the urgency of …

Objectives HIV and tuberculosis (TB) are major global health threats and can result in
household financial hardships. Here, we aim to estimate the household economic burden …

Despite national programs covering the cost of treatment for tuberculosis (TB) in many
countries, TB patients still face substantial costs. The end TB strategy, set by the World …